Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00120081 · ClinicalTrials.gov registry record · Phase 1
Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection
A Phase 1 study of Hookworm Infection, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT00120081 is a Phase 1 study of Hookworm Infection that has completed, run by Baylor College of Medicine. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00120081, a Phase 1 study of Hookworm Infection, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this clinical trial is to determine the safety and tolerability of the Na-ASP-2 Hookworm Vaccine in healthy subjects following the administration of 3 intramuscular (IM) injections of the vaccine over 16 weeks using 3 different doses. The secondary objective is to make a preliminary evaluation of the immunogenicity of each of the 3 doses of the vaccine in healthy volunteers.
Conditions Studied
Interventions
- BIOLOGICAL Saline placebo
- BIOLOGICAL Na-ASP-2/Alhydrogel Hookworm Vaccine
Study Locations (1)
District of Columbia
- George Washington University Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2005-04 |
| Est. Completion | 2006-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00120081
The ClinicalTrials.gov registry entry for NCT00120081 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hookworm Infection appearing as the primary indexed condition, and to 2 interventions - of which Saline placebo is the first listed.
NCT00120081 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00120081 about?
NCT00120081 is a clinical study titled "Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection". The primary objective of this clinical trial is to determine the safety and tolerability of the Na-ASP-2 Hookworm Vaccine in healthy subjects following the administration of 3 intramuscular (IM) injections of the vaccine over 16 weeks using 3 different doses. The secondary objective is to make a pre...
What is the current status of trial NCT00120081?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2005-04. Estimated completion is 2006-09.
What conditions does trial NCT00120081 study?
This clinical trial studies the following conditions: Hookworm Infection.
What interventions are being tested in trial NCT00120081?
The interventions under investigation include: Saline placebo (BIOLOGICAL), Na-ASP-2/Alhydrogel Hookworm Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00120081?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00120081 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hookworm Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.